Global Pharmaceutical Consortium Being Created to Expand Predictive Toxicology Resource
Primary Human Cell and Co-Culture Assay Systems for Oncology Highly Predictive of Drug Activity in<br /> Relation to Inflammation, Neo-Vascularization and Tumor Microenvironments<br /> <br /> Capabilities for Cancer Drug Discovery Highlighted in ‘Advanced Drug Delivery Reviews’ Publication<br /> and American Association of Cancer Research 2014 Meeting Presentations<br />
Activities Include a Complimentary Workshop on Analysis of Failed Pharmaceutical Compounds Profiled in Primary Human Cell Systems Using BioMAP<sup>®</sup>
Joint Publication Identifies Clinical Kinase Inhibitors that Potently Cross React with Bromodomain Epigenetic Reader Proteins